Today, ACUVUE® Brand Soft Disposable Contact Lenses remain the number one brand in the world. The ACUVUE® Brand is worn by more people globally than any other contact lens brand. The ACUVUE® Brand is truly transforming the world's vision by providing an outstanding range of contact lens options to meet the vision needs and wants of just about everyone requiring vision correction.About this brand
Acuvue Oasys for Astigmatism
Why ask for them?
Maybe you've been told you can't wear contacts because you have astigmatism. Or perhaps you're experiencing discomfort, blurred or fluctuating vision with your current lenses. Now with ACUVUE® OASYS® Brand for ASTIGMATISM you can leave all that behind.
We combined the visual stability of our revolutionary Accelerated Stabilization Design and the exceptional comfort of HYDRACLEAR® Plus technology to form a lens like no other. The result is consistently clear vision that's remarkably comfortable – even for people with an active lifestyle.
Accelerated Stabilization Design (ASD) uses the power of every blink to help keep your vision crisp, clear, and stable all day long - even for people with an active lifestyle.
ASD helps minimize shifting and lens rotation to keep your lenses right where they need to be. ASD lenses feature four zones of stability, instead of the single ballast zone found in most astigmatic lenses. The result is exceptional stability and crisp vision.
Bedford Eye Care is a Finalist for Business of the Year!
We are so very grateful to our patients, the community and the outstanding service team in the practice for the support you all continue to show to us in our many years in business.
We're honoured to be selected by the Halifax Chamber of Commerce among a diverse group of outstanding and well-known finalists for this prestigious award. We believe it's a reflection of the commitment we have to delivering the highest quality care to our patients and for pushing into new areas of innovative care, including our new dry eye and traumatic brain injury clinics, as well as our commitment to patient and public education in these critical new areas of research and treatment.